Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 5/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 10/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6584844 | 0.89 | CAMK2D (0.37) | ICMTHSP90AA1CNR1CNR2PIM1 | |
| SCHEMBL27581115 | 0.88 | HSP90AA1 (0.37) | HSP90AA1PIM1CAMK2D | |
| SCHEMBL6588554 | 0.87 | GSK3B (0.34) | HSP90AA1PIM1CAMK2D | |
| Trifluoroacetic Acid SCHEMBL6588928 | 0.83 | HSP90AA1 (0.34) | HSP90AA1 | |
| Trifluoroacetic Acid SCHEMBL6588931 | 0.83 | HSP90AA1 (0.34) | HSP90AA1 | |
| SCHEMBL6588231 | 0.82 | CAMK2D (0.51) | PIM1CAMK2D | |
| SCHEMBL6588981 | 0.82 | CAMK2D (0.42) | ICMTHSP90AA1PIM1CAMK2D | |
| SCHEMBL6586537 | 0.81 | PIM1 (0.40) | ICMTHSP90AA1PIM1CAMK2D | |
| Hydrochloric Acid SCHEMBL6588778 | 0.81 | CAMK2D (0.42) | ICMTHSP90AA1PIM1CAMK2D | |
| SCHEMBL27560071 | 0.81 | HSP90AA1 (0.38) | HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1183252-B1 | PHARMACEUTICALLY ACTIVE COMPOUNDS | ASTRAZENECA AB (SE) | 2004-02-18 | — | — | EP | disclosed |
| US-6492406-B1 | PROTEIN KINASE C INHIBITORS; ANTIINFLAMMATORY AND IMMUNO-SUPPRESSIVE AGENTS | ASTRAZENECA AB (SE) | 2002-12-10 | — | — | US | disclosed |
| EP-1183252-A1 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | AstraZeneca AB (SE) | 2002-03-06 | — | — | EP | disclosed |
| WO-2000071537-A1 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | ASTRAZENECA AB (SE) | 2000-11-30 | — | — | WO | disclosed |